Clinical Trials Directory

Trials / Completed

CompletedNCT05766332

Evaluating Clinical Evaluation Tools for Predicting Risk of Complications After Hematopoietic Stem Cell Transplant

Developing Novel Tools for Determining Risk of Respiratory Complications Following Hematopoietic Stem Cell Transplant

Status
Completed
Phase
Study type
Observational
Enrollment
137 (actual)
Sponsor
Mayo Clinic · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study evaluates whether clinical evaluation tools such as the six-minute walk test, hand grip strength test, and gait speed test, are useful in predicting risk of complications in patients undergoing hematopoietic stem cell transplants (HCT). Being able to predict who is at increased risk of post-HCT complications can help better inform patients and providers on the risks and benefits of undergoing HCT and determine whether certain patients should have closer post-HCT monitoring due to an increased risk of complications.

Detailed description

PRIMARY OBJECTIVE: I. To develop novel pre-transplant tools for determining risk of post-HCT pulmonary complications. OUTLINE: This is an observational study. Patients undergo a clinical evaluation consisting of a six-minute walk test, hand grip strength test, and gait speed test on study. Patients' medical records are also reviewed for a year on study.

Conditions

Interventions

TypeNameDescription
OTHERClinical EvaluationUndergo clinical evaluation
OTHERElectronic Health Record ReviewMedical records reviewed

Timeline

Start date
2021-08-02
Primary completion
2023-11-17
Completion
2023-11-17
First posted
2023-03-13
Last updated
2025-01-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05766332. Inclusion in this directory is not an endorsement.